On Wednesday, the Cabinet of the Duchy of Luxembourg agreed to a reform of the Narcotics Act to allow the use of medical cannabis at an undetermined future date. Despite the new law, patients in Luxembourg will continue to have zero access to pharmacy-grade herbal cannabis.
Due to the perceived danger of over- or underdosing medical marijuana, there will be no flowers available for Luxembourgian patients, yet. Although there is already a licensed medical device in the neighboring country of Germany that’s capable of providing accurate dosing, patients have to put up with processed medicine and extracts from pharmaceutical companies until a standard device for medical use is approved in Luxembourg.
Incidentally, the vaporizer was only approved in Germany in 2015 because it allows for precise dosing of the herb.
During the announcement of the government’s intention to reform the Narcotics Act in November, Luxembourg’s PM Xavier Bettel made it clear that the use of medical marijuana would be strictly regulated and controlled.
“Cannabis is not a cure,” the Prime Minister said. “However, it can very well relieve pain in chronic conditions … and not every doctor will be able to prescribe it.”
According to the new law, only neurologists, cancer doctors, and internists will be allowed to prescribe the medicine to patients. They must first apply for a “prescription permission” and therapeutically substantiate an “exceptional situation.”
The delivery of cannabis medicine will not take place through regular pharmacies as in Germany, Czech, or the Netherlands, but exclusively through hospital pharmacies.